By Professor Jason Grebely

Journal articles

Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J; InC , 2015, 'Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC³ study', Journal of Viral Hepatitis, 22, pp. 708 - 717, http://dx.doi.org/10.1111/jvh.12384

Barua S; Greenwald R; Grebely J; Dore GJ; Swan T; Taylor LE, 2015, 'Restrictions for medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States', Annals of Internal Medicine, 163, pp. 215 - 223, http://dx.doi.org/10.7326/m15-0406

Lamoury FMJ; Jacka B; Bartlett S; Bull RA; Wong A; Amin J; Schinkel J; Poon AF; Matthews GV; Grebely J; Dore GJ; Applegate TL, 2015, 'The influence of hepatitis C virus genetic region on phylogenetic clustering analysis', PLoS ONE, 10, pp. e0131437, http://dx.doi.org/10.1371/journal.pone.0131437

Olmstead AD; Joy JB; Montoya V; Luo I; Poon AFY; Jacka B; Lamoury F; Applegate T; Montaner J; Khudyakov Y; Grebely J; Cook D; Harrigan PR; Krajden M, 2015, 'A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events', Infection, Genetics and Evolution, 33, pp. 101 - 109, http://dx.doi.org/10.1016/j.meegid.2015.04.017

Cunningham EB; Jacka B; DeBeck K; Applegate TL; Harrigan PR; Krajden M; Marshall BDL; Montaner J; Lima VD; Olmstead AD; Milloy MJ; Wood E; Grebely J, 2015, 'Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada', Drug and Alcohol Dependence, 152, pp. 272 - 276, http://dx.doi.org/10.1016/j.drugalcdep.2015.04.005

Montoya V; Olmstead AD; Janjua NZ; Tang P; Grebely J; Cook D; Richard Harrigan P; Krajden M, 2015, 'Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: A population-level tool for incidence estimation', Hepatology, 61, pp. 1842 - 1850, http://dx.doi.org/10.1002/hep.27734

Cunningham EB; Applegate TL; Lloyd AR; Dore GJ; Grebely J, 2015, 'Mixed HCV infection and reinfection in people who inject drugs-impact on therapy', Nature Reviews Gastroenterology and Hepatology, 12, pp. 218 - 230, http://dx.doi.org/10.1038/nrgastro.2015.36

Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Dore GJ; Grebely J, 2015, 'Patterns of hepatitis C Virus RNA levels during acute infection: The InC³ study', PLoS ONE, 10, pp. e0122232, http://dx.doi.org/10.1371/journal.pone.0122232

Sacks-Davis R; McBryde E; Grebely J; Hellard M; Vickerman P, 2015, 'Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data', Journal of the Royal Society Interface, 12, pp. 20141197, http://dx.doi.org/10.1098/rsif.2014.1197

Larney S; Grebely J; Falster M; Swart A; Amin J; Degenhardt L; Burns L; Vajdic CM, 2015, 'Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: A 15-year observational cohort study', Drug and Alcohol Dependence, 148, pp. 213 - 216, http://dx.doi.org/10.1016/j.drugalcdep.2014.12.027

Bruggmann P; Grebely J, 2015, 'Prevention, treatment and care of hepatitis C virus infection among people who inject drugs', International Journal of Drug Policy, 26, pp. S22 - S26, http://dx.doi.org/10.1016/j.drugpo.2014.08.014

Spelman T; Morris MD; Zang G; Rice T; Page K; Maher L; Lloyd A; Grebely J; Dore GJ; Kim AY; Shoukry NH; Hellard M; Bruneau J; Cox AL; Lauer G; McGovern BH; Prins M; Hahn J; Shiboski S; Mirzazadeh A; Alavi M; Bouchard R; Evans J; Grady B; Aneja J; Sacks-Davis R; Teutsch S; White B; Wells B; Applegate T; Matthews G; Yeung B; Schinkel J; Prince LE; Roy E; Bates A; Enriquez J; Chow S; McCredie L; Aitken C; Doyle J, 2015, 'A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs', Journal of Epidemiology and Community Health, 69, pp. 745 - 752, http://dx.doi.org/10.1136/jech-2014-205224

Grebely J; Robaeys G; Bruggmann P; Aghemo A; Backmund M; Bruneau J; Byrne J; Dalgard O; Feld JJ; Hellard M; Hickman M; Kautz A; Litwin A; Lloyd AR; Mauss S; Prins M; Swan T; Schaefer M; Taylor LE; Dore GJ, 2015, 'Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden', International Journal of Drug Policy, 111, pp. 101670, http://dx.doi.org/10.1016/j.drugpo.2015.11.010

Lamoury FMJ; Bartlett S; Jacka B; Hajarizadeh B; Grebely J; Matthews GV; Dore GJ; Applegate TL, 2015, 'Interferon λ 3 and 4 genotyping using high-resolution melt curve analysis suitable for multiple clinical sample types', Journal of Molecular Diagnostics, 17, pp. 583 - 589, http://dx.doi.org/10.1016/j.jmoldx.2015.05.003

Eslam M; Hashem AM; Leung R; Romero-Gomez M; Berg T; Dore GJ; Chan HLK; Irving WL; Sheridan D; Abate ML; Adams LA; Mangia A; Weltman M; Bugianesi E; Spengler U; Shaker O; Fischer J; Mollison L; Cheng W; Powell E; Nattermann J; Riordan S; McLeod D; Armstrong NJ; Douglas MW; Liddle C; Booth DR; George J; Ahlenstiel G; Ampuero J; Bassendine M; Wong VWS; Rosso C; White R; Mezzabotta L; Suppiah V; Michalk M; Malik B; Matthews G; Applegate T; Grebely J; Fragomeli V; Jonsson JR; Santaro R, 2015, 'Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease', Nature Communications, 6, pp. 6422, http://dx.doi.org/10.1038/ncomms7422

Applegate TL; Gaudieri S; Plauzolles A; Chopra A; Grebely J; Lucas M; Hellard M; Luciani F; Dore GJ; Matthews GV, 2015, 'Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C', Antiviral Therapy, 20, pp. 199 - 208, http://dx.doi.org/10.3851/IMP2821

Aspinall EJ; Hutchinson SJ; Janjua NZ; Grebely J; Yu A; Alavi M; Amin J; Goldberg DJ; Innes H; Law M; Walter SR; Krajden M; Dore GJ; Han A, 2015, 'Trends in mortality after diagnosis of hepatitis C virus infection: An international comparison and implications for monitoring the population impact of treatment', Journal of Hepatology, 62, pp. 269 - 277, http://dx.doi.org/10.1016/j.jhep.2014.09.001

Larney S; Grebely J; Falster M; Swart A; Amin J; Degenhardt L; Burns L; Vajdic C, 2015, 'Diagnosis of hepatitis c virus infection after entry to opioid substitution therapy', Drug and Alcohol Dependence, 156, pp. e122 - e122, http://dx.doi.org/10.1016/j.drugalcdep.2015.07.337

Grebely J; Bruggmann P; Treloar C; Byrne J; Rhodes T; Dore GJ, 2015, 'Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs', International Journal of Drug Policy, 26, pp. 893 - 898, http://dx.doi.org/10.1016/j.drugpo.2015.07.007

Grebely J; Dore GJ; Kim AY; Lloyd A; Shoukry NH; Prins M; Page K, 2014, 'Genetics of spontaneous clearance of hepatitis C virus infection: A complex topic with much to learn', Hepatology, 60, pp. 2127 - 2128, http://dx.doi.org/10.1002/hep.27163

Nolan S; Dias Lima V; Fairbairn N; Kerr T; Montaner J; Grebely J; Wood E, 2014, 'The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users', Addiction, 109, pp. 2053 - 2059, http://dx.doi.org/10.1111/add.12682

Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J; Lauer G; Shoukry NH; Hahn J; Shiboski S; Rice TM; Alavi M; Bouchard R; Aneja J; Teutsch S; White B; Wells B; Zang G; Matthews G; Marks P; Yeung B; Prince LE; Roy E; Bates A; Enriquez J; Chow S; McCredie L; Aitken C; Doyle J; Spelman T; Evans J, 2014, 'Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: The InC³ Study', Journal of Clinical Virology, 61, pp. 430 - 434, http://dx.doi.org/10.1016/j.jcv.2014.08.027

Jacka B; Applegate T; Krajden M; Olmstead A; Harrigan PR; Marshall BDL; Debeck K; Milloy MJ; Lamoury F; Pybus OG; Lima VD; Magiorkinis G; Montoya V; Montaner J; Joy J; Woods C; Dobrer S; Dore GJ; Poon AFY; Grebely J, 2014, 'Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada', Hepatology, 60, pp. 1571 - 1580, http://dx.doi.org/10.1002/hep.27310

Hajarizadeh B; Grebely J; Applegate T; Matthews GV; Amin J; Petoumenos K; Hellard M; Rawlinson W; Lloyd A; Kaldor J; Dore GJ; Dolan K, 2014, 'Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection', Journal of Medical Virology, 86, pp. 1722 - 1729, http://dx.doi.org/10.1002/jmv.24010

MacParland SA; Bilodeau M; Grebely J; Bruneau J; Cooper C; Klein M; Sagan SM; Choucha N; Balfour L; Bialystok F; Krajden M; Raven J; Roberts E; Russell R; Houghton M; Tyrrell DL; Feld JJ; Butt G; Conway B; Edwards A; Fischer B; Götte M; Kneteman N; Krahn M; Levy G; Liu Q; McGilvray I; Michalak T; Mugford G; Myers R; Ostrowski M; Pause A; Pezacki J; Richardson C; Schang L; Shoukry N; Sonenberg N; Soudeyns H; Tellier R; Tyndall M; Wilson J; Boisvert M; Depla M; Dupont B; Ehteshami M; Issur M; Olmstead A; Sarhan M; Siu R; Van Buuren N; Ablenas C; Bernier A; Cunningham E; Fabre T; Fahmy A; Hoffman B; Hyrina A; Kofahi H; Kulkarni A; Moqueet N; Ardakan NN; Singaravelu R; Thibault P; Wu Q; Artenie A; Puzhko S; Saeed S; Taylor N; Wong J; Cumming A, 2014, 'The 3rd Canadian symposium on Hepatitis c Virus: Expanding care in the interferon-free era', Canadian Journal of Gastroenterology and Hepatology, 28, pp. 481 - 487, http://dx.doi.org/10.1155/2014/704919

Grebely J; Lima VD; Marshall BDL; Milloy MJ; DeBeck K; Montaner J; Simo A; Krajden M; Dore GJ; Kerr T; Wood E, 2014, 'Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012', PLoS ONE, 9, pp. e97726, http://dx.doi.org/10.1371/journal.pone.0097726

Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L, 2014, 'Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011', Journal of Viral Hepatitis, 21, pp. 198 - 207, http://dx.doi.org/10.1111/jvh.12129

Treloar C; Rance J; Dore GJ; Grebely J, 2014, 'Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: Insights from the ETHOS study', Journal of Viral Hepatitis, 21, pp. 560 - 567, http://dx.doi.org/10.1111/jvh.12183

Grebely J; Dore GJ, 2014, 'Can hepatitis C virus infection be eradicated in people who inject drugs?', Antiviral Research, 104, pp. 62 - 72, http://dx.doi.org/10.1016/j.antiviral.2014.01.002

Alavi M; Raffa JD; Deans GD; Lai C; Krajden M; Dore GJ; Tyndall MW; Grebely J, 2014, 'Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents', Liver International, 34, pp. 1198 - 1206, http://dx.doi.org/10.1111/liv.12370

Baker D; Alavi M; Erratt A; Hill S; Balcomb A; Hallinan R; Siriragavan S; Richmond D; Smart J; Keats J; Doong N; Marks P; Grebely J; Dore GJ, 2014, 'Delivery of treatment for hepatitis C virus infection in the primary care setting', European Journal of Gastroenterology and Hepatology, 26, pp. 1003 - 1009, http://dx.doi.org/10.1097/MEG.0000000000000150

Baker D; Alavi M; Erratt A; Hill S; Balcomb A; Hallinan R; Siriragavan S; Richmond D; Smart J; Keats J; Doong N; Marks P; Grebely J; Dore GJ, 2014, 'Delivery of treatment for hepatitis C virus infection in the primary care setting', Journal of Nursing Administration, 44, pp. 1003 - 1009, http://dx.doi.org/10.1097/meg.0000000000000150

Grebely J; Grady B; Hajarizadeh B; Page K; Dore GJ, 2014, 'Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels?', Hepatology, 59, pp. 1650 - 1651, http://dx.doi.org/10.1002/hep.26675

Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME, 2014, 'Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the networks ii study', International Journal of Drug Policy, 25, pp. 179 - 182, http://dx.doi.org/10.1016/j.drugpo.2013.08.005

Alavi M; Law MG; Grebely J; Thein HH; Walter S; Amin J; Dore GJ; Han A, 2014, 'Lower life expectancy among people with an HCV notification: A population-based linkage study', Journal of Viral Hepatitis, 21, pp. e10 - e18, http://dx.doi.org/10.1111/jvh.12245

Grebely J; Page K; Sacks-Davis R; van der Loeff MS; Rice TM; Bruneau J; Morris MD; Hajarizadeh B; Amin J; Cox AL; Kim AY; Mcgovern BH; Schinkel J; George J; Shoukry NH; Lauer GM; Maher L; Lloyd AR; Hellard M; Dore GJ; Prins M, 2014, 'The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection', Hepatology, 59, pp. 109 - 120, http://dx.doi.org/10.1002/hep.26639

Treloar C; Rance J; Grebely J; Marks P; Dore G, 2014, 'How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting', International Journal of Drug Policy, 25, pp. 865 - 870, http://dx.doi.org/10.1016/j.drugpo.2014.01.011

Olmstead A; Krajden M; Montoya V; Grebely J; Poon AFY; Harrigan PR; Joy JB, 2014, 'P232 MOLECULAR PHYLOGENETICS OF HEPATITIS C VIRUS (HCV) AS A TOOL TO UNDERSTAND THE HCV EPIDEMIC IN BRITISH COLUMBIA (BC), CANADA', Journal of Hepatology, 60, pp. S143 - S143, http://dx.doi.org/10.1016/s0168-8278(14)60394-9

Treloar C; Rance J; Grebely J; Dore GJ, 2013, 'Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia', Drug and Alcohol Dependence, 133, pp. 529 - 534, http://dx.doi.org/10.1016/j.drugalcdep.2013.07.023

Feld JJ; Grebely J; Matthews GV; Applegate T; Hellard M; Sherker A; Cherepanov V; Petoumenos K; Yeung B; Kaldor JM; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection', PLoS ONE, 8, pp. e80003, http://dx.doi.org/10.1371/journal.pone.0080003

Sacks-Davis R; Aitken CK; Higgs P; Spelman T; Pedrana AE; Bowden S; Bharadwaj M; Nivarthi UK; Suppiah V; George J; Grebely J; Drummer HE; Hellard M, 2013, 'High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: A prospective cohort study', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0080216

Martin NK; Vickerman P; Grebely J; Hellard M; Hutchinson SJ; Lima VD; Foster GR; Dillon JF; Goldberg DJ; Dore GJ; Hickman M, 2013, 'Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals', Hepatology, 58, pp. 1598 - 1609, http://dx.doi.org/10.1002/hep.26431

Grebely J; Matthews GV; Lloyd AR; Dore GJ, 2013, 'Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: Feasibility and future requirements', Clinical Infectious Diseases, 57, pp. 1014 - 1020, http://dx.doi.org/10.1093/cid/cit377

Hajarizadeh B; Grebely J; Dore GJ, 2013, 'Epidemiology and natural history of HCV infection', Nature Reviews Gastroenterology and Hepatology, 10, pp. 553 - 562, http://dx.doi.org/10.1038/nrgastro.2013.107

Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ, 2013, 'Assessment and treatment of hepatitis c virus infection among people who inject drugs in the opioid substitution setting: ETHOS study', Clinical Infectious Diseases, 57, pp. s62 - s69, http://dx.doi.org/10.1093/cid/cit305

Hilsden RJ; Macphail G; Grebely J; Conway B; Lee SS, 2013, 'Directly observed pegylated interferon plus self-administered ribavirin for the treatment of hepatitis C virus infection in people actively using drugs: A randomized controlled trial', Clinical Infectious Diseases, 57, http://dx.doi.org/10.1093/cid/cit327

Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ, 2013, 'Recommendations for the management of hepatitis C virus infection among people who inject drugs', Clinical Infectious Diseases, 57, pp. s129 - s137, http://dx.doi.org/10.1093/cid/cit302

Aspinall EJ; Corson S; Doyle JS; Grebely J; Hutchinson SJ; Dore GJ; Goldberg DJ; Hellard ME, 2013, 'Treatment of hepatitis c virus infection among people who are actively injecting drugs: A systematic review and meta-analysis', Clinical Infectious Diseases, 57, pp. s80 - s89, http://dx.doi.org/10.1093/cid/cit306

Jacka B; Lamoury F; Simmonds P; Dore GJ; Grebely J; Applegate T, 2013, 'Sequencing of the Hepatitis C Virus: A Systematic Review', PLoS ONE, 8, pp. e67073, http://dx.doi.org/10.1371/journal.pone.0067073

Grebely J; Feld JJ; Applegate T; Matthews GV; Hellard M; Sherker A; Petoumenos K; Zang G; Shaw I; Yeung B; George J; Teutsch S; Kaldor JM; Cherepanov V; Bruneau J; Shoukry NH; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection', Hepatology, 57, pp. 2124 - 2134, http://dx.doi.org/10.1002/hep.26263

Back to profile page